Blood clots in the lungs, medically known as pulmonary embolism, happen when a clot-usually from a deep vein in the leg-breaks loose and travels through the bloodstream to block an artery in the lung. This condition can be life-threatening if not treated promptly.
Pulmonary embolism accounts for approximately 10% of all hospital deaths in the United States, according to the American Heart Association. It often develops silently, with symptoms appearing suddenly during physical activity or rest. Early recognition and treatment reduce mortality risk.
Most clots that reach the lungs originate in the deep veins of the lower limbs-a condition called deep vein thrombosis (DVT). When blood flow slows due to immobility, injury, or genetic predisposition, platelets and fibrin accumulate into a solid mass. If this clot dislodges, it enters the venous system and moves toward the heart and lungs.
The right side of the heart pumps blood into the pulmonary arteries. A large clot can lodge in a major branch, causing a partial or complete blockage. This prevents oxygen-rich blood from reaching lung tissue, leading to tissue damage and impaired gas exchange.
A 2021 study published in *The Lancet* found that nearly 60% of pulmonary embolism cases were associated with prior DVT. Risk factors include prolonged bed rest, recent surgery, cancer, pregnancy, and oral contraceptive use. Individuals with inherited clotting disorders such as factor V Leiden have a 5- to 10-fold increased risk.
Clots vary in size and location. Small emboli may affect only peripheral vessels and cause mild symptoms. Larger ones can occlude central pulmonary arteries, leading to acute respiratory failure.
| Type | Size | Common Cause | Risk Level |
|---|---|---|---|
| Small embolus | <5% of pulmonary artery | Minor DVT, prolonged sitting | Moderate |
| Large embolus | 10-30% of main pulmonary artery | Post-surgical, trauma | High |
| Massive embolus | Blocks main pulmonary trunk | Severe DVT, hypercoagulable state | Life-threatening |
Non-thrombotic causes exist but are rare. Air, fat, amniotic fluid, or tumor fragments can also block pulmonary vessels. These are termed non-thrombotic emboli and require different diagnostic approaches.
One underreported trigger is long-haul air travel. A 2019 study in *JAMA Internal Medicine* showed that flying for more than four hours increases DVT risk by 2.5 times, especially in individuals with pre-existing conditions like obesity or varicose veins.
Symptoms of blood clots in the lungs include sudden shortness of breath, sharp chest pain worsened by breathing deeply, coughing up blood, rapid heartbeat, and lightheadedness. Some people report anxiety or a feeling of impending doom.
Because these signs mimic heart attacks, pneumonia, or panic attacks, misdiagnosis occurs in up to 30% of cases, per research from the National Institutes of Health. Patients often undergo multiple tests before the correct diagnosis is made.
A common confusion is equating pulmonary embolism with pleurisy. While both involve chest pain and breathing difficulty, pleurisy results from inflammation of the lung lining, not vascular obstruction. A CT pulmonary angiogram confirms the presence of a clot, while ultrasound or MRI may detect DVT in the legs.
Doctors use a combination of clinical assessment, D-dimer blood test, and imaging. A positive D-dimer indicates clot breakdown products in the blood but is not specific to pulmonary embolism. False positives occur in infection, trauma, or advanced age.
Imaging is definitive. A CT pulmonary angiogram visualizes clots in the pulmonary arteries with 95% accuracy. For patients who cannot receive contrast dye, ventilation-perfusion (V/Q) scanning is an alternative.
Treatment depends on severity. Low-risk patients may receive anticoagulants like rivaroxaban or apixaban. High-risk cases require thrombolytic drugs such as alteplase to dissolve the clot rapidly. In massive embolism, surgical embolectomy may be necessary.
I experienced this firsthand during a medical rotation: a 52-year-old woman presented with unexplained dyspnea after a hip replacement. Her D-dimer was elevated. A CT scan revealed a clot in the right pulmonary artery. She was started on enoxaparin and later transitioned to oral anticoagulation. She recovered fully within six weeks.
Prevention focuses on reducing DVT risk. Compression stockings, early mobilization after surgery, and anticoagulant prophylaxis are standard in hospitals. Patients with a history of DVT or pulmonary embolism are advised to avoid long periods of sitting and maintain hydration.
Survival rates improve dramatically with timely treatment. The 30-day mortality rate drops from 30% to less than 5% when anticoagulants are initiated within 24 hours of diagnosis, according to the European Society of Cardiology guidelines.
Long-term management includes regular monitoring and adherence to medication. Recurrence risk remains around 10% within five years, especially in those with ongoing risk factors like cancer or inherited thrombophilia.
Blood clots in the lungs are preventable and treatable. Early detection saves lives. Recognizing symptoms and understanding risk factors reduces morbidity and mortality.